---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-110368"
form_type: "8-K"
ticker: "CYTK"
cik: "0001061983"
company_name: "CYTOKINETICS INC"
filed_at: "2025-08-20T23:59:59+00:00"
generated_at: "2026-05-17T11:03:31.822365+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Cytokinetics appoints James M. Daly to Board of Directors as Class III member

## Summary
- James M. Daly appointed to Board effective August 19, 2025, as Class III director, term expiring at 2028 annual meeting.
- Daly also appointed to Compliance Committee; determined independent under SEC and Nasdaq rules.
- Annual director compensation: $50,000 retainer, $7,500 Compliance retainer, plus $440,000 equity grant.
- Initial option grant of 27,450 shares ($700,000 fair value) vesting over three years.
- No arrangements or transactions requiring disclosure under Item 404(a).

## SEC filing metadata
- accession: 0000950170-25-110368
- form_type: 8-K
- ticker: CYTK
- cik: 0001061983
- company_name: CYTOKINETICS INC
- filed_at: 2025-08-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061983/000095017025110368/0000950170-25-110368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061983/000095017025110368/cytk-20250819.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-110368
- JSON: https://secwatch.observer/filing/0000950170-25-110368.json
- Plain text: https://secwatch.observer/filing/0000950170-25-110368.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.